nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—CYP1A2—chronic obstructive pulmonary disease	0.352	1	CbGaD
Etoricoxib—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0499	0.12	CbGbCtD
Etoricoxib—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0368	0.0884	CbGbCtD
Etoricoxib—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0368	0.0884	CbGbCtD
Etoricoxib—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0306	0.0735	CbGbCtD
Etoricoxib—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0306	0.0735	CbGbCtD
Etoricoxib—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0289	0.0694	CbGbCtD
Etoricoxib—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.028	0.0672	CbGbCtD
Etoricoxib—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.028	0.0672	CbGbCtD
Etoricoxib—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0249	0.0599	CbGbCtD
Etoricoxib—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0235	0.0564	CbGbCtD
Etoricoxib—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0232	0.0557	CbGbCtD
Etoricoxib—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0159	0.0381	CbGbCtD
Etoricoxib—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0155	0.0371	CbGbCtD
Etoricoxib—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0151	0.0363	CbGbCtD
Etoricoxib—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0135	0.0324	CbGbCtD
Etoricoxib—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00791	0.019	CbGbCtD
Etoricoxib—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00747	0.0179	CbGbCtD
Etoricoxib—Vemurafenib—CYP1A2—chronic obstructive pulmonary disease	0.00164	0.453	CrCbGaD
Etoricoxib—PTGS2—leg—chronic obstructive pulmonary disease	0.00114	0.153	CbGeAlD
Etoricoxib—MAPK14—respiratory system—chronic obstructive pulmonary disease	0.000984	0.132	CbGeAlD
Etoricoxib—Vemurafenib—ALB—chronic obstructive pulmonary disease	0.000946	0.262	CrCbGaD
Etoricoxib—MAPK14—connective tissue—chronic obstructive pulmonary disease	0.000866	0.116	CbGeAlD
Etoricoxib—MAPK14—bronchus—chronic obstructive pulmonary disease	0.00081	0.109	CbGeAlD
Etoricoxib—MAPK14—smooth muscle tissue—chronic obstructive pulmonary disease	0.000792	0.106	CbGeAlD
Etoricoxib—Celecoxib—ALB—chronic obstructive pulmonary disease	0.000556	0.154	CrCbGaD
Etoricoxib—MAPK14—lung—chronic obstructive pulmonary disease	0.000523	0.07	CbGeAlD
Etoricoxib—Vismodegib—ALB—chronic obstructive pulmonary disease	0.000476	0.132	CrCbGaD
Etoricoxib—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000342	0.0458	CbGeAlD
Etoricoxib—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000307	0.0412	CbGeAlD
Etoricoxib—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000283	0.0379	CbGeAlD
Etoricoxib—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000249	0.0334	CbGeAlD
Etoricoxib—PTGS2—bronchus—chronic obstructive pulmonary disease	0.000233	0.0312	CbGeAlD
Etoricoxib—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000228	0.0305	CbGeAlD
Etoricoxib—PTGS2—trachea—chronic obstructive pulmonary disease	0.000209	0.028	CbGeAlD
Etoricoxib—CYP1A2—lung—chronic obstructive pulmonary disease	0.000181	0.0243	CbGeAlD
Etoricoxib—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.00124	CcSEcCtD
Etoricoxib—Cough—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00124	CcSEcCtD
Etoricoxib—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000179	0.00124	CcSEcCtD
Etoricoxib—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00124	CcSEcCtD
Etoricoxib—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00124	CcSEcCtD
Etoricoxib—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00124	CcSEcCtD
Etoricoxib—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00124	CcSEcCtD
Etoricoxib—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00123	CcSEcCtD
Etoricoxib—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00123	CcSEcCtD
Etoricoxib—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000179	0.00123	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.00123	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000178	0.00123	CcSEcCtD
Etoricoxib—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000178	0.00123	CcSEcCtD
Etoricoxib—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00121	CcSEcCtD
Etoricoxib—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00121	CcSEcCtD
Etoricoxib—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00121	CcSEcCtD
Etoricoxib—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00121	CcSEcCtD
Etoricoxib—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00121	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000174	0.0012	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000174	0.0012	CcSEcCtD
Etoricoxib—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.0012	CcSEcCtD
Etoricoxib—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000172	0.00119	CcSEcCtD
Etoricoxib—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.00119	CcSEcCtD
Etoricoxib—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.00119	CcSEcCtD
Etoricoxib—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000172	0.00119	CcSEcCtD
Etoricoxib—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00119	CcSEcCtD
Etoricoxib—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00118	CcSEcCtD
Etoricoxib—Infection—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00118	CcSEcCtD
Etoricoxib—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00118	CcSEcCtD
Etoricoxib—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00117	CcSEcCtD
Etoricoxib—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00117	CcSEcCtD
Etoricoxib—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000169	0.00117	CcSEcCtD
Etoricoxib—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00116	CcSEcCtD
Etoricoxib—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00116	CcSEcCtD
Etoricoxib—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00116	CcSEcCtD
Etoricoxib—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000168	0.00116	CcSEcCtD
Etoricoxib—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000168	0.00116	CcSEcCtD
Etoricoxib—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000168	0.00116	CcSEcCtD
Etoricoxib—Infection—Montelukast—chronic obstructive pulmonary disease	0.000167	0.00115	CcSEcCtD
Etoricoxib—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00115	CcSEcCtD
Etoricoxib—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00115	CcSEcCtD
Etoricoxib—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00115	CcSEcCtD
Etoricoxib—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000166	0.00115	CcSEcCtD
Etoricoxib—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00114	CcSEcCtD
Etoricoxib—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00114	CcSEcCtD
Etoricoxib—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00114	CcSEcCtD
Etoricoxib—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.00114	CcSEcCtD
Etoricoxib—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000164	0.00113	CcSEcCtD
Etoricoxib—CYP2E1—lung—chronic obstructive pulmonary disease	0.000163	0.0219	CbGeAlD
Etoricoxib—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00112	CcSEcCtD
Etoricoxib—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00112	CcSEcCtD
Etoricoxib—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00111	CcSEcCtD
Etoricoxib—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.00111	CcSEcCtD
Etoricoxib—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00016	0.0011	CcSEcCtD
Etoricoxib—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.0011	CcSEcCtD
Etoricoxib—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.0011	CcSEcCtD
Etoricoxib—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00109	CcSEcCtD
Etoricoxib—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00109	CcSEcCtD
Etoricoxib—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000157	0.00108	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.00108	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000157	0.00108	CcSEcCtD
Etoricoxib—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00107	CcSEcCtD
Etoricoxib—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00107	CcSEcCtD
Etoricoxib—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.00107	CcSEcCtD
Etoricoxib—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000155	0.00107	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000153	0.00106	CcSEcCtD
Etoricoxib—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00106	CcSEcCtD
Etoricoxib—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00106	CcSEcCtD
Etoricoxib—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00106	CcSEcCtD
Etoricoxib—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00106	CcSEcCtD
Etoricoxib—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000152	0.00105	CcSEcCtD
Etoricoxib—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000152	0.00105	CcSEcCtD
Etoricoxib—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00104	CcSEcCtD
Etoricoxib—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00104	CcSEcCtD
Etoricoxib—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000151	0.00104	CcSEcCtD
Etoricoxib—PTGS2—lung—chronic obstructive pulmonary disease	0.00015	0.0201	CbGeAlD
Etoricoxib—Injury—Prednisone—chronic obstructive pulmonary disease	0.00015	0.00103	CcSEcCtD
Etoricoxib—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00103	CcSEcCtD
Etoricoxib—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000149	0.00103	CcSEcCtD
Etoricoxib—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.00103	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00102	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00102	CcSEcCtD
Etoricoxib—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00102	CcSEcCtD
Etoricoxib—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.00102	CcSEcCtD
Etoricoxib—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000148	0.00102	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.00102	CcSEcCtD
Etoricoxib—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00101	CcSEcCtD
Etoricoxib—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00101	CcSEcCtD
Etoricoxib—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.00101	CcSEcCtD
Etoricoxib—Pain—Formoterol—chronic obstructive pulmonary disease	0.000147	0.00101	CcSEcCtD
Etoricoxib—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00101	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000145	0.001	CcSEcCtD
Etoricoxib—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000145	0.001	CcSEcCtD
Etoricoxib—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.000999	CcSEcCtD
Etoricoxib—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.000996	CcSEcCtD
Etoricoxib—Pain—Montelukast—chronic obstructive pulmonary disease	0.000144	0.000994	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000993	CcSEcCtD
Etoricoxib—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000144	0.000991	CcSEcCtD
Etoricoxib—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.000988	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.000988	CcSEcCtD
Etoricoxib—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.000986	CcSEcCtD
Etoricoxib—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000142	0.000983	CcSEcCtD
Etoricoxib—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000142	0.000982	CcSEcCtD
Etoricoxib—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.00098	CcSEcCtD
Etoricoxib—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000978	CcSEcCtD
Etoricoxib—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000978	CcSEcCtD
Etoricoxib—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000141	0.000977	CcSEcCtD
Etoricoxib—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000141	0.000974	CcSEcCtD
Etoricoxib—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.000972	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000141	0.00097	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.00097	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.000967	CcSEcCtD
Etoricoxib—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.000966	CcSEcCtD
Etoricoxib—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000958	CcSEcCtD
Etoricoxib—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000958	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000138	0.000951	CcSEcCtD
Etoricoxib—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00095	CcSEcCtD
Etoricoxib—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000137	0.000943	CcSEcCtD
Etoricoxib—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.000943	CcSEcCtD
Etoricoxib—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.000938	CcSEcCtD
Etoricoxib—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000136	0.000938	CcSEcCtD
Etoricoxib—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000135	0.000935	CcSEcCtD
Etoricoxib—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000134	0.000927	CcSEcCtD
Etoricoxib—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000134	0.000926	CcSEcCtD
Etoricoxib—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000134	0.000926	CcSEcCtD
Etoricoxib—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000134	0.000923	CcSEcCtD
Etoricoxib—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000923	CcSEcCtD
Etoricoxib—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000133	0.000921	CcSEcCtD
Etoricoxib—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000133	0.000919	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.000916	CcSEcCtD
Etoricoxib—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000909	CcSEcCtD
Etoricoxib—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.000905	CcSEcCtD
Etoricoxib—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000904	CcSEcCtD
Etoricoxib—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.00089	CcSEcCtD
Etoricoxib—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000886	CcSEcCtD
Etoricoxib—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.000874	CcSEcCtD
Etoricoxib—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000127	0.000874	CcSEcCtD
Etoricoxib—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000127	0.000873	CcSEcCtD
Etoricoxib—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000872	CcSEcCtD
Etoricoxib—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000124	0.000856	CcSEcCtD
Etoricoxib—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000123	0.000851	CcSEcCtD
Etoricoxib—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.000851	CcSEcCtD
Etoricoxib—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.00084	CcSEcCtD
Etoricoxib—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000122	0.00084	CcSEcCtD
Etoricoxib—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000838	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000838	CcSEcCtD
Etoricoxib—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000121	0.000834	CcSEcCtD
Etoricoxib—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000827	CcSEcCtD
Etoricoxib—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000826	CcSEcCtD
Etoricoxib—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000119	0.000822	CcSEcCtD
Etoricoxib—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000118	0.000812	CcSEcCtD
Etoricoxib—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.000812	CcSEcCtD
Etoricoxib—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000117	0.000808	CcSEcCtD
Etoricoxib—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000805	CcSEcCtD
Etoricoxib—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000804	CcSEcCtD
Etoricoxib—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000795	CcSEcCtD
Etoricoxib—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.000793	CcSEcCtD
Etoricoxib—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000788	CcSEcCtD
Etoricoxib—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.000785	CcSEcCtD
Etoricoxib—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000114	0.000785	CcSEcCtD
Etoricoxib—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000769	CcSEcCtD
Etoricoxib—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000767	CcSEcCtD
Etoricoxib—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000109	0.000755	CcSEcCtD
Etoricoxib—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.000755	CcSEcCtD
Etoricoxib—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000748	CcSEcCtD
Etoricoxib—Rash—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000748	CcSEcCtD
Etoricoxib—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000748	CcSEcCtD
Etoricoxib—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000748	CcSEcCtD
Etoricoxib—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000747	CcSEcCtD
Etoricoxib—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000743	CcSEcCtD
Etoricoxib—Headache—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000743	CcSEcCtD
Etoricoxib—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.000742	CcSEcCtD
Etoricoxib—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000741	CcSEcCtD
Etoricoxib—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000107	0.000741	CcSEcCtD
Etoricoxib—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000107	0.000739	CcSEcCtD
Etoricoxib—Rash—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000733	CcSEcCtD
Etoricoxib—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000732	CcSEcCtD
Etoricoxib—Headache—Montelukast—chronic obstructive pulmonary disease	0.000105	0.000728	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000722	CcSEcCtD
Etoricoxib—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.00072	CcSEcCtD
Etoricoxib—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000718	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000718	CcSEcCtD
Etoricoxib—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000712	CcSEcCtD
Etoricoxib—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000707	CcSEcCtD
Etoricoxib—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000706	CcSEcCtD
Etoricoxib—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000102	0.000705	CcSEcCtD
Etoricoxib—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000102	0.000705	CcSEcCtD
Etoricoxib—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000702	CcSEcCtD
Etoricoxib—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0001	0.00069	CcSEcCtD
Etoricoxib—Hypertension—Prednisolone—chronic obstructive pulmonary disease	9.85e-05	0.00068	CcSEcCtD
Etoricoxib—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.64e-05	0.000666	CcSEcCtD
Etoricoxib—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	9.57e-05	0.000661	CcSEcCtD
Etoricoxib—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.52e-05	0.000657	CcSEcCtD
Etoricoxib—Hallucination—Prednisone—chronic obstructive pulmonary disease	9.47e-05	0.000654	CcSEcCtD
Etoricoxib—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	9.36e-05	0.000646	CcSEcCtD
Etoricoxib—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	9.31e-05	0.000643	CcSEcCtD
Etoricoxib—Oedema—Prednisolone—chronic obstructive pulmonary disease	9.31e-05	0.000643	CcSEcCtD
Etoricoxib—Shock—Prednisolone—chronic obstructive pulmonary disease	9.16e-05	0.000632	CcSEcCtD
Etoricoxib—Eye disorder—Prednisone—chronic obstructive pulmonary disease	8.9e-05	0.000614	CcSEcCtD
Etoricoxib—Flushing—Prednisone—chronic obstructive pulmonary disease	8.84e-05	0.00061	CcSEcCtD
Etoricoxib—Angiopathy—Prednisone—chronic obstructive pulmonary disease	8.64e-05	0.000596	CcSEcCtD
Etoricoxib—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	8.6e-05	0.000594	CcSEcCtD
Etoricoxib—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	8.51e-05	0.000587	CcSEcCtD
Etoricoxib—Insomnia—Prednisolone—chronic obstructive pulmonary disease	8.42e-05	0.000581	CcSEcCtD
Etoricoxib—Alopecia—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.000581	CcSEcCtD
Etoricoxib—Mental disorder—Prednisone—chronic obstructive pulmonary disease	8.34e-05	0.000576	CcSEcCtD
Etoricoxib—Malnutrition—Prednisone—chronic obstructive pulmonary disease	8.29e-05	0.000572	CcSEcCtD
Etoricoxib—Erythema—Prednisone—chronic obstructive pulmonary disease	8.29e-05	0.000572	CcSEcCtD
Etoricoxib—Pain—Prednisolone—chronic obstructive pulmonary disease	7.96e-05	0.00055	CcSEcCtD
Etoricoxib—Vision blurred—Prednisone—chronic obstructive pulmonary disease	7.81e-05	0.000539	CcSEcCtD
Etoricoxib—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	7.67e-05	0.00053	CcSEcCtD
Etoricoxib—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.000529	CcSEcCtD
Etoricoxib—Agitation—Prednisone—chronic obstructive pulmonary disease	7.62e-05	0.000526	CcSEcCtD
Etoricoxib—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.57e-05	0.000523	CcSEcCtD
Etoricoxib—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.4e-05	0.000511	CcSEcCtD
Etoricoxib—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.16e-05	0.000494	CcSEcCtD
Etoricoxib—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.06e-05	0.000487	CcSEcCtD
Etoricoxib—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.03e-05	0.000486	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	7.01e-05	0.000484	CcSEcCtD
Etoricoxib—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.86e-05	0.000474	CcSEcCtD
Etoricoxib—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.76e-05	0.000467	CcSEcCtD
Etoricoxib—Oedema—Prednisone—chronic obstructive pulmonary disease	6.76e-05	0.000467	CcSEcCtD
Etoricoxib—Infection—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000464	CcSEcCtD
Etoricoxib—Shock—Prednisone—chronic obstructive pulmonary disease	6.66e-05	0.000459	CcSEcCtD
Etoricoxib—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.63e-05	0.000458	CcSEcCtD
Etoricoxib—Skin disorder—Prednisone—chronic obstructive pulmonary disease	6.57e-05	0.000454	CcSEcCtD
Etoricoxib—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.45e-05	0.000445	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000426	CcSEcCtD
Etoricoxib—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.16e-05	0.000425	CcSEcCtD
Etoricoxib—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.12e-05	0.000422	CcSEcCtD
Etoricoxib—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.95e-05	0.000411	CcSEcCtD
Etoricoxib—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.000406	CcSEcCtD
Etoricoxib—Rash—Prednisolone—chronic obstructive pulmonary disease	5.87e-05	0.000405	CcSEcCtD
Etoricoxib—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.86e-05	0.000405	CcSEcCtD
Etoricoxib—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.83e-05	0.000403	CcSEcCtD
Etoricoxib—Headache—Prednisolone—chronic obstructive pulmonary disease	5.83e-05	0.000403	CcSEcCtD
Etoricoxib—Constipation—Prednisone—chronic obstructive pulmonary disease	5.78e-05	0.000399	CcSEcCtD
Etoricoxib—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.57e-05	0.000385	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.53e-05	0.000382	CcSEcCtD
Etoricoxib—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.53e-05	0.000382	CcSEcCtD
Etoricoxib—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.37e-05	0.000371	CcSEcCtD
Etoricoxib—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.35e-05	0.000369	CcSEcCtD
Etoricoxib—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.98e-05	0.000344	CcSEcCtD
Etoricoxib—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.85e-05	0.000335	CcSEcCtD
Etoricoxib—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.79e-05	0.00033	CcSEcCtD
Etoricoxib—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.63e-05	0.00032	CcSEcCtD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL6—chronic obstructive pulmonary disease	4.6e-05	0.000609	CbGpPWpGaD
Etoricoxib—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.58e-05	0.000607	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	4.57e-05	0.000605	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—chronic obstructive pulmonary disease	4.56e-05	0.000603	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—chronic obstructive pulmonary disease	4.55e-05	0.000602	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—IL6—chronic obstructive pulmonary disease	4.53e-05	0.0006	CbGpPWpGaD
Etoricoxib—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.47e-05	0.000309	CcSEcCtD
Etoricoxib—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.44e-05	0.000588	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.42e-05	0.000585	CbGpPWpGaD
Etoricoxib—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.38e-05	0.00058	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.37e-05	0.000579	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—IL6—chronic obstructive pulmonary disease	4.34e-05	0.000574	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	4.31e-05	0.000571	CbGpPWpGaD
Etoricoxib—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.31e-05	0.00057	CbGpPWpGaD
Etoricoxib—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.3e-05	0.000297	CcSEcCtD
Etoricoxib—MAPK14—Signaling by VEGF—IL6—chronic obstructive pulmonary disease	4.28e-05	0.000566	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	4.27e-05	0.000566	CbGpPWpGaD
Etoricoxib—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.27e-05	0.000565	CbGpPWpGaD
Etoricoxib—Rash—Prednisone—chronic obstructive pulmonary disease	4.27e-05	0.000294	CcSEcCtD
Etoricoxib—MAPK14—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.26e-05	0.000565	CbGpPWpGaD
Etoricoxib—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.26e-05	0.000294	CcSEcCtD
Etoricoxib—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.25e-05	0.000562	CbGpPWpGaD
Etoricoxib—Headache—Prednisone—chronic obstructive pulmonary disease	4.24e-05	0.000293	CcSEcCtD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—EGFR—chronic obstructive pulmonary disease	4.23e-05	0.00056	CbGpPWpGaD
Etoricoxib—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.21e-05	0.000558	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.2e-05	0.000555	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	4.19e-05	0.000555	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	4.19e-05	0.000555	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	4.19e-05	0.000555	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TP53—chronic obstructive pulmonary disease	4.19e-05	0.000554	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.12e-05	0.000546	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—EGFR—chronic obstructive pulmonary disease	4.11e-05	0.000544	CbGpPWpGaD
Etoricoxib—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.08e-05	0.000541	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—IL6—chronic obstructive pulmonary disease	4.08e-05	0.00054	CbGpPWpGaD
Etoricoxib—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.05e-05	0.000536	CbGpPWpGaD
Etoricoxib—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.03e-05	0.000533	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.03e-05	0.000533	CbGpPWpGaD
Etoricoxib—Nausea—Prednisone—chronic obstructive pulmonary disease	4.02e-05	0.000277	CcSEcCtD
Etoricoxib—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.99e-05	0.000529	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	3.99e-05	0.000528	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	3.99e-05	0.000528	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.97e-05	0.000526	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	3.92e-05	0.000519	CbGpPWpGaD
Etoricoxib—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.92e-05	0.000519	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TNF—chronic obstructive pulmonary disease	3.92e-05	0.000518	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.78e-05	0.000501	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.71e-05	0.000491	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	3.68e-05	0.000487	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.67e-05	0.000487	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	3.67e-05	0.000486	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.65e-05	0.000483	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	3.63e-05	0.000481	CbGpPWpGaD
Etoricoxib—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.62e-05	0.00048	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—MMP1—chronic obstructive pulmonary disease	3.62e-05	0.000479	CbGpPWpGaD
Etoricoxib—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.6e-05	0.000477	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	3.57e-05	0.000473	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—LEP—chronic obstructive pulmonary disease	3.57e-05	0.000473	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—PLAU—chronic obstructive pulmonary disease	3.55e-05	0.00047	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	3.55e-05	0.00047	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.53e-05	0.000468	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	3.53e-05	0.000467	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.51e-05	0.000464	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	3.49e-05	0.000462	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	3.48e-05	0.000461	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.46e-05	0.000458	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	3.45e-05	0.000457	CbGpPWpGaD
Etoricoxib—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.41e-05	0.000452	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.39e-05	0.000448	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	3.37e-05	0.000446	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	3.32e-05	0.000439	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	3.29e-05	0.000435	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—NOS2—chronic obstructive pulmonary disease	3.26e-05	0.000432	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.26e-05	0.000431	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	3.26e-05	0.000431	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.23e-05	0.000428	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.23e-05	0.000428	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CRP—chronic obstructive pulmonary disease	3.22e-05	0.000427	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	3.18e-05	0.000421	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—TP53—chronic obstructive pulmonary disease	3.18e-05	0.000421	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	3.17e-05	0.00042	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—CTGF—chronic obstructive pulmonary disease	3.14e-05	0.000416	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.11e-05	0.000412	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TLR4—chronic obstructive pulmonary disease	3.09e-05	0.000409	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.07e-05	0.000406	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.07e-05	0.000406	CbGpPWpGaD
Etoricoxib—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.02e-05	0.0004	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	2.98e-05	0.000395	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.95e-05	0.00039	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.93e-05	0.000388	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	2.93e-05	0.000387	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TLR2—chronic obstructive pulmonary disease	2.91e-05	0.000386	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—IL6—chronic obstructive pulmonary disease	2.91e-05	0.000386	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.82e-05	0.000373	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	2.78e-05	0.000368	CbGpPWpGaD
Etoricoxib—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.78e-05	0.000368	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.77e-05	0.000367	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.75e-05	0.000364	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—ALB—chronic obstructive pulmonary disease	2.74e-05	0.000363	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—KL—chronic obstructive pulmonary disease	2.74e-05	0.000363	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	2.69e-05	0.000356	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	2.68e-05	0.000355	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	2.68e-05	0.000354	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.67e-05	0.000353	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.63e-05	0.000349	CbGpPWpGaD
Etoricoxib—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.63e-05	0.000349	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.62e-05	0.000347	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.61e-05	0.000345	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.55e-05	0.000337	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.42e-05	0.00032	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	2.4e-05	0.000318	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.37e-05	0.000314	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.37e-05	0.000313	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.35e-05	0.000311	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.35e-05	0.000311	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.32e-05	0.000307	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.3e-05	0.000305	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.26e-05	0.000299	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD8A—chronic obstructive pulmonary disease	2.21e-05	0.000292	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	2.2e-05	0.000291	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.18e-05	0.000288	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.16e-05	0.000286	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.15e-05	0.000284	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.15e-05	0.000284	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.14e-05	0.000283	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.14e-05	0.000283	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	2.12e-05	0.00028	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	2.1e-05	0.000278	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IL6—chronic obstructive pulmonary disease	2.06e-05	0.000273	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ERBB3—chronic obstructive pulmonary disease	2.05e-05	0.000272	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.99e-05	0.000263	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.98e-05	0.000263	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.97e-05	0.000261	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.95e-05	0.000258	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.93e-05	0.000255	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.9e-05	0.000252	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.89e-05	0.00025	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CRP—chronic obstructive pulmonary disease	1.88e-05	0.000249	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.84e-05	0.000244	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TLR4—chronic obstructive pulmonary disease	1.8e-05	0.000238	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.79e-05	0.000237	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.77e-05	0.000234	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.77e-05	0.000234	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	1.74e-05	0.00023	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.74e-05	0.00023	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.73e-05	0.00023	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.73e-05	0.000229	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.71e-05	0.000227	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.71e-05	0.000226	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.67e-05	0.000221	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.65e-05	0.000219	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.63e-05	0.000216	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.63e-05	0.000216	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—KL—chronic obstructive pulmonary disease	1.62e-05	0.000214	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.61e-05	0.000213	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.6e-05	0.000211	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.56e-05	0.000207	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.55e-05	0.000206	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.53e-05	0.000203	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.47e-05	0.000195	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.46e-05	0.000193	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.44e-05	0.000191	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.43e-05	0.00019	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—chronic obstructive pulmonary disease	1.43e-05	0.000189	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.42e-05	0.000188	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.38e-05	0.000183	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.35e-05	0.000179	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.33e-05	0.000176	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.33e-05	0.000176	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.33e-05	0.000176	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.29e-05	0.00017	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.28e-05	0.000169	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.26e-05	0.000166	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.24e-05	0.000165	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	1.21e-05	0.00016	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.2e-05	0.000159	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.19e-05	0.000157	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.000157	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—chronic obstructive pulmonary disease	1.18e-05	0.000156	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1B—chronic obstructive pulmonary disease	1.17e-05	0.000155	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.16e-05	0.000153	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.16e-05	0.000153	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.15e-05	0.000152	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.14e-05	0.000151	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.13e-05	0.00015	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.13e-05	0.00015	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.13e-05	0.00015	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.11e-05	0.000148	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.000146	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.06e-05	0.00014	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.05e-05	0.000138	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.05e-05	0.000138	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	1.04e-05	0.000138	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.04e-05	0.000137	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.03e-05	0.000137	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	1.01e-05	0.000134	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.84e-06	0.00013	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.8e-06	0.00013	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	9.69e-06	0.000128	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.61e-06	0.000127	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.53e-06	0.000126	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.32e-06	0.000123	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.03e-06	0.00012	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—EGFR—chronic obstructive pulmonary disease	8.92e-06	0.000118	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.9e-06	0.000118	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	8.84e-06	0.000117	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.72e-06	0.000115	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.6e-06	0.000114	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	8.5e-06	0.000113	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	8.12e-06	0.000107	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.02e-06	0.000106	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.01e-06	0.000106	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.95e-06	0.000105	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.91e-06	0.000105	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.89e-06	0.000104	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.84e-06	0.000104	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.59e-06	0.000101	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.56e-06	0.0001	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	7.48e-06	9.9e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.37e-06	9.75e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.3e-06	9.67e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.14e-06	9.45e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	7.11e-06	9.41e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.98e-06	9.25e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.92e-06	9.17e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—chronic obstructive pulmonary disease	6.86e-06	9.08e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.82e-06	9.03e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.8e-06	9e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.79e-06	8.99e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.7e-06	8.87e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	6.69e-06	8.86e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.41e-06	8.49e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.4e-06	8.47e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.28e-06	8.32e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.24e-06	8.26e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.92e-06	7.83e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.88e-06	7.79e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.77e-06	7.64e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	5.37e-06	7.11e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	5.26e-06	6.97e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.24e-06	6.94e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.17e-06	6.84e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.16e-06	6.83e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.94e-06	6.54e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.84e-06	6.41e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.82e-06	6.38e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.75e-06	6.29e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	4.71e-06	6.23e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.57e-06	6.05e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.54e-06	6.01e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	4.5e-06	5.96e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.43e-06	5.87e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	4.04e-06	5.35e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	4.02e-06	5.32e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	3.85e-06	5.09e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.1e-06	4.11e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.97e-06	3.93e-05	CbGpPWpGaD
